Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.16.2 (
PCP
)
3,761
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It has been reported that glutamate can increase the binding of [3H]
TCP
to phencyclidine (
PCP
) receptors by an action on receptors which are selective for N-methyl-D-aspartate (NMDA). Recently this laboratory has reported that glycine and magnesium can amplify this effect of NMDA agonists in well-washed, lysed cortical membranes. Here we report that maximally effective concentrations of glutamate (10 microM), NMDA (300 microM), MgCl2 (300 microM) and glycine (10 microM) increase the affinity of the
PCP
receptor for [3H]
TCP
by approximately 4-fold in the absence of any change in the density of
PCP
receptors. However, in combination with glutamate, magnesium had the further effect of increasing the Bmax by about 75%. Finally, a synaptosomal P2 preparation, which had not been washed to minimize the concentration of endogenous effectors had a Bmax value similar to the well-washed preparation, but had a KD value 8-fold lower. These data indicate that the primary effect of NMDA agonists, glycine, and low concentrations of magnesium ions is to convert the
PCP
receptor from a low-affinity to a high-affinity state. These data are discussed in relation to the functional regulation of the NMDA ionophore.
...
PMID:Equilibrium analysis of [3H]TCP binding: effects of glycine, magnesium and N-methyl-D-aspartate agonists. 306 29
MK-801 was found to be more potent than phencyclidine (
PCP
) as an inhibitor of N-methyl-D-aspartate-induced [3H]norepinephrine (NE) release and [3H]
TCP
binding in the hippocampus. On the other hand, MK-801 was slightly less potent than
PCP
to enhance kainate-stimulated [3H]NE release and to inhibit hippocampal [3H]NE uptake. Further, MK-801 was strikingly less potent than
PCP
as an inhibitor of striatal synaptosomal [3H]dopamine uptake. These data are discussed with reference to the therapeutic potential of MK-801.
...
PMID:Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release. 328 Mar 29
The inhibition of [3H]
TCP
binding to rat cortical membranes by substances of the
PCP
/sigma-opiate type was compared with effects of the same compounds on N-methyl-D-aspartate (NMDA) responses in cultured mouse cortex neurons. A new technique of excitatory amino acid-induced [3H]GABA (gamma-amino-butyric acid) release in a continuous superfusion model was used for the purpose. A similar rank order of potencies was found for the substances whether as inhibitors of [3H]
TCP
binding (MK 801 greater than
PCP
greater than ketamine-cyclazocine) or as antagonists of NMDA (20 microM)-stimulated [3H]GABA release in the cultured neurons (phencyclidine = MK 801 greater than ketamine greater than cyclazocine).
...
PMID:Phencyclidine analogues inhibit NMDA-stimulated [3H]GABA release from cultured cortex neurons. 331 51
In extensively washed preparations of rat cortical membranes, N-methyl-D-aspartate (NMDA) increases the specific binding of [3H]
TCP
by over 4-fold in a concentration dependent manner (EC50 = 3.1 microM). Glycine (1 microM) potentiates the maximal effect of NMDA by a factor of 1.7. The effect of glycine is concentration dependent (EC50 = 380 nM) and strychnine insensitive. These data are discussed with reference to the recently reported effects of glycine on the NMDA operated cation channel and the relationship between the
PCP
and NMDA receptors.
...
PMID:Glycine potentiates N-methyl-D-aspartate-induced [3H]TCP binding to rat cortical membranes. 332 17
Brown oxidation of cis-bicyclo[3.1.0]hexan-3-ol afforded bicyclo[3.1.0]hexan-3-one in 98% yield. Treatment of this ketone with either phenyllithium or phenylamagnesium bromide in ether at room temperature followed by solvolysis of the resulting alcohol in a mixture of trifluoroacetic acid, sodium azide, and chloroform gave a mixture of cis- and trans-3-azido-3-phenylbicyclo[3.1.0]hexanes. LAH reduction of this crude mixture of azides afforded a 1:3.5 mixture of cis- and trans-3-phenyl-3-bicyclo[3.1.0]hexylamine, respectively, in 51% overall yield from the alcohol. Separation of the mixture of amines by column chromatography followed by cyclization of each by heating at 60 degrees C in DMF solution with 1 equiv of 1,5-dibromopentane furnished the two conformationally restrained analogues of phencyclidine (
PCP
), cis- and trans-3-phenyl-3-piperidinylbicyclo[3.1.0]hexane (1 and 2, respectively), in high yield. Configurations were assigned on the basis of an X-ray crystallographic analysis of the cis isomer (1). Bond lengths and angles are similar to those found in
PCP
and its derivatives. Binding to
PCP
receptors and sigma sites as well as behavioral effects of 1 and 2 in rats was determined relative to
PCP
. In displacement of specifically bound [3H]
TCP
(1-[1-(2-thienyl)cyclohexyl]piperidine) from
PCP
receptors, 1 and 2 were nearly equipotent and about one-seventh as potent as
PCP
. These compounds were about one-fifth as potent as
PCP
in displacing [3H]-(+)-SKF 10,047 from its binding site. Calculation of the ED50 values of 1 and 2 for stereotyped behavior and ataxia indicated that they were about equipotent, and 2-3-fold less active than
PCP
.
...
PMID:Synthesis, configuration, and evaluation of two conformationally restrained analogues of phencyclidine. 339 94
The interactions of the hallucinogenic drug
PCP
[1-(1-phenylcyclohexyl)piperidine] and some of its analogs with the nicotinic acetylcholine receptor-ionic channel complex were studied using electrophysiological techniques. The peak amplitude and the decay time constant of the nerve-evoked end-plate current (EPCs) recorded from the frog sartorius muscle were reduced by all the analogs in a concentration-dependent manner (IC50 between 5 and 90 microM).
PCP
,
TCP
[1-[1-(2-thienyl)cyclohexyl]-piperidine] and PCE (N-ethyl-1-phenylcyclohexylamine), among other analogs, caused a negative slope conductance in the current-voltage relationship at hyperpolarized potentials and a voltage- and time-dependent depression of the peak amplitude of the EPC. When the piperidine ring of the
PCP
molecule was substituted by a morpholino ring, as in 1-(1-phenylcyclohexyl)morpholine and 1-[1-(2-thienyl)-cyclohexyl]morpholine, the potency decreased and the negative conductance was eliminated. The removal of the piperidine ring of
PCP
in 1-phenylcyclohexylamine and the hydroxylation of the cyclohexane ring in 4-phenyl-4-piperidino-cyclohexanol reduced the potency and produced double exponential decays at potentials between +50 and -50 mV. At -100 mV, the potency for decreasing peak EPC amplitude was well correlated with the potency for reducing the decay time constant for all the analogs. The voltage- and time-dependent depression of the EPC amplitude was reduced by substitution of a morpholino ring and by the elimination of the piperidine ring of
PCP
. The behaviorally active analogs were the most potent EPC blockers, which suggests a synaptic role for the production of depressant behavioral effects observed with
PCP
.
...
PMID:Effects of phencyclidine and its analogs on the end-plate current of the neuromuscular junction. 348 35
1 Urinary chlorophenols of the general population of Barcelona, Spain were determined. Pentachlorophenol (
PCP
: 25.0 +/- 3.9 ng/ml; mean +/- s.e.m., n = 50) and tetrachlorophenol (
TCP
: 6.2 +/- 1.6 ng/ml; mean +/- s.e.m., n = 25) were found in all samples. 2 Pentachlorophenol and hexachlorobenzene were also determined in serum. Both were present in all samples (
PCP
: 21.9 +/- 1.9 ng/ml; HCB: 11.1 +/- 1.1 ng/ml; mean +/- s.e.m., n = 100). Their concentrations do not show any correlation, suggesting no metabolic relation between them.
...
PMID:Pentachlorophenol and hexachlorobenzene in serum and urine of the population of Barcelona. 367 48
A high affinity [3H]thienyl-phencyclidine ([3H]
TCP
) binding and its similarity to that of [3H]phencyclidine ([3H]
PCP
) have been demonstrated on whole rat brain homogenates. We now describe the regional distribution of the [3H]
TCP
binding sites in the rat brain with fixed sections and frozen slide-mounted sections visualized by autoradiography and with homogenates of 12 regions by direct binding experiments. The 3 techniques give a similar pattern for the [3H]
TCP
binding distribution and the biochemical study reveals that two distinct binding sites for [3H]
TCP
exist: one of high affinity (5-10 nM) in the forebrain, which should be responsible for the psychotropic effects and a second one of lower affinity (50-80 nM) in the hindbrain and the spinal cord, which should be involved in the extrapyramidal behavior induced by
PCP
and congeneers. Competition experiments have shown that muscarinic compounds interact only with the hindbrain receptor possibly in two different sites, although morphine interacts with a very low affinity with the forebrain's high affinity receptor. Results obtained with SKF-10,047 (N-allylnormetazocine) seem to indicate that
TCP
and sigma-receptors are different.
...
PMID:[3H]thienyl-phencyclidine ([3H]TCP) binds to two different sites in rat brain. Localization by autoradiographic and biochemical techniques. 374 96
Myotubes grown in culture provided a convenient experimental system for the study of the effects of phencyclidine (
PCP
) and analog drugs on both acetylcholine receptor (AChR) function and on its binding properties. The extent of
PCP
retention by these cells was studied on the same preparations.
PCP
, N-ethyl-l-phenylcyclohexylamine (PCE),
PCP
methiodide (PCPMeI), 1-[1-(3-aminophenyl)-cyclohexyl] piperidine (NH2PCP) and 1-[1-(2-thienyl)cyclohexyl] piperidine (
TCP
) were found to inhibit carbamylcholine (CbCh)-induced 22Na and 45Ca ion fluxes with 50% inhibition (I50) at 2-6 microM drug concentration. The I50 for CbCh-induced 42K+ efflux was 8-20 microM. Ketamine was less efficient with an I50 of 100 microM. Binding of [125I] alpha-bungarotoxin [( 125I]alpha-BGT) was not affected at drug concentrations that cause 100% inhibition of ion fluxes. Retention of [3H]
PCP
by the myotubes was a saturable process with half-maximal saturation at approximately 20 microM
PCP
. It was inhibited by
PCP
and several tertiary analogs, with and I50 of approximately 20 microM. PCPMeI was much less effective, with an I50 of 1 mM. PCPMeI was, however, as potent as
PCP
in its inhibition of the AChR function although the amount retained by the cells was 50-fold lower than that of
PCP
. These results are consistent with the theory that
PCP
and analog drugs affect AChR at a site other than the alpha-BGT binding site, possibly at the ionic channel of the nicotinic receptor.
...
PMID:Effects of phencyclidine and analog drugs on acetylcholine receptor of cultured muscle cells. 398 98
The effects of N-(1-phenylcyclohexyl) piperidine (
PCP
) and related drugs on isolated intact segments of the guinea-pig ileum were determined. 1-1-(2-Thienyl) cyclohexylpiperidine (
TCP
),
PCP
and ketamine decreased the height of electrically induced contractions (0.1 Hz) of intact segments of isolated guinea-pig ileum. Thirty to forty percent of the inhibition of contraction height (0.1 Hz) was reversed by pretreatment with the pure narcotic antagonist, naloxone. This naloxone-reversible component showed cross-tolerance with morphine.
PCP
pretreatment caused a shift to the right in the dose-response curve to acetylcholine (ACh) that was not parallel with the control dose-response curve. Thus
PCP
does not interact with the muscarinic cholinoceptor in a strictly atropine-like competitive fashion. Binding sites for [3H]-
PCP
were detected in homogenates of the guinea-pig longitudinal muscle-myenteric plexus preparation. The affinity constants and the rank order of potencies of various
PCP
derivatives competing with [3H]-
PCP
for binding suggest that these binding sites are very similar to those found in the central nervous system. These data suggest that the guinea-pig isolated ileum may be used as an in vitro system for studying the mechanism of action of phencyclidines.
...
PMID:Effects of phencyclidine and its derivatives on enteric neurones. 631 7
<< Previous
1
2
3
4
5
6
7
8
9
10